Company intelligence / Profile preview

Lakota Antibodies

Brookings, South Dakota, United States

Ownership: Private
Development stage: Other

Overview

Lakota Antibodies is a biotechnology company specializing in the development and production of high-quality polyclonal antibodies for the life sciences industry. Based in Brookings, South Dakota, the company utilizes a proprietary platform focused on large-animal immunization to generate high-titer and high-affinity antibodies. Their services encompass the entire antibody production lifecycle, including antigen design, immunization, and advanced purification techniques. Lakota Antibodies provides critical reagents for research, diagnostic assays, and therapeutic development to academic and commercial partners. The company is recognized for its expertise in handling complex antigens and producing large-scale antibody lots.

Modalities: AntibodyPolyclonal antibody
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Lakota Antibodies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lakota Antibodies.

Explore the full profile